Unicycive Therapeutics, Inc. (UNCY) - Quarterly Income Statement

Home
UNCY
Financials

0.4347 (USD) • At close October 21, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	-0.271	0	0	0.675	0	0.951	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.284	0.082	0.079	0.078	0.045	0.002	0.001	0.002	0.002	0.001	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	-0.284	-0.353	-0.079	-0.078	0.63	-0.002	0.95	-0.002	-0.002	-0.001	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	1.303	0	0	0.933	0	0.999	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	4.868	6.813	4.233	3.372	2.267	3.03	3.84	4.803	1.86	1.933	1.361	3.776	0.493	0.45	0.382	0.304	0.182	0.148	0.376	0.188	0.116	0.116
General & Administrative Expenses Numbers are in millions	2.533	2.391	2.08	2.566	2.055	1.847	1.485	1.702	1.776	1.604	1.391	0.939	0.286	0.281	0.335	0.322	0.154	0.194	0.325	0.293	0.275	0.275
Selling & Marketing Expenses Numbers are in millions	0	-0.284	-0.082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	2.533	2.107	1.998	2.566	2.055	1.847	1.485	1.702	1.776	1.604	1.391	0.939	0.286	0.281	0.335	0.322	0.154	0.194	0.325	0.293	0.275	0.275
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	7.401	8.92	6.231	5.938	4.322	4.877	5.325	6.505	3.636	3.537	2.752	4.715	0.779	0.731	0.717	0.626	0.336	0.342	0.701	0.544	0.391	0.391
Operating Income Numbers are in millions	-7.401	-9.204	-6.313	-5.938	-4.322	-4.202	-5.325	-5.554	-3.636	-3.537	-2.752	-4.715	-0.779	-0.731	-0.717	-0.626	-0.336	-0.342	-0.701	-0.481	-0.391	-0.391
Operating Income Ratio Numbers are in millions	0	0	23.295	0	0	-6.225	0	-5.84	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	17.256	-11.759	-1.485	1.533	0.282	-10.373	-0.003	-0.003	0	0	0	-0.431	-0.321	0.019	-0.163	-0.076	-0.002	-0.002	-0.001	-0.083	-0.059	-0.059
Income Before Tax Numbers are in millions	9.855	-20.963	-7.798	-4.405	-3.838	-14.575	-5.328	-5.557	-3.636	-3.537	-2.752	-5.201	-1.1	-0.964	-0.88	-0.702	-0.338	-0.344	-0.702	-0.564	-0.45	-0.45
Income Before Tax Ratio Numbers are in millions	0	0	28.775	0	0	-21.593	0	-5.843	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	5.925	0.241	-10.53	-0.079	0.032	10.577	0.003	0.003	0.038	0.037	-0.412	0.431	-0.779	-0.019	-0.717	-0.626	-0.336	-0.342	-0.001	-0.083	-0.059	-0.059
Net Income Numbers are in millions	3.93	-20.963	-7.798	-4.405	-3.838	-25.152	-5.331	-5.56	-3.636	-3.537	-2.752	-5.201	-1.1	-0.964	-0.88	-0.702	-0.338	-0.344	-0.702	-0.564	-0.45	-0.45
Net Income Ratio Numbers are in millions	0	0	28.775	0	0	-37.262	0	-5.846	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	0.08	-0.6	-0.22	-0.13	-0.25	-1.65	-0.35	-0.37	-0.24	-0.24	-0.19	-0.37	-0.079	-0.11	-0.061	-0.083	-0.04	-0.024	-0.084	-0.069	-0.057	-0.057
EPS Diluted Numbers are in millions	0.08	-0.6	-0.22	-0.13	-0.25	-1.65	-0.35	-0.37	-0.24	-0.24	-0.19	-0.37	-0.079	-0.11	-0.061	-0.082	-0.039	-0.024	-0.084	-0.069	-0.057	-0.057
EBITDA Numbers are in millions	-7.401	-8.92	-6.231	-5.938	-4.01	-4.143	-5.283	-5.514	-3.596	-3.498	-2.752	-4.715	-0.779	-0.731	-0.717	-0.626	-0.336	-0.342	-0.001	-0.083	-0.059	-0.059
EBITDA Ratio Numbers are in millions	0	0	22.993	0	0	-6.138	0	-5.798	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Unicycive Therapeutics, Inc.

NASDAQ:UNCY Add to watchlist

NASDAQ:UNCY